Clinical Trial Record

Return to Clinical Trials

Registry for Advanced Endoscopy


2022-01-14


2032-01-14


2032-01-14


1000

Study Overview

Registry for Advanced Endoscopy

Observational registry including endoscopic diagnostic and therapeutic interventions in the gastrointestinal tract

N/A

  • Cholangiocarcinoma
  • Pancreatic Cancer
  • Sclerosing Cholangitis
  • PROCEDURE: Endoscopic retrograde Cholangio- pancreatography
  • PROCEDURE: Endoscopic ultrasound
  • 2021-7616

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates Results Reporting Dates Study Record Updates

2021-12-25  

N/A  

2024-04-11  

2021-12-25  

N/A  

2024-04-12  

2022-01-11  

N/A  

2024-04  

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

Design Details

Primary Purpose:
N/A


Allocation:
N/A


Interventional Model:
N/A


Masking:
N/A


Arms and Interventions

Participant Group/ArmIntervention/Treatment
Primary Outcome MeasuresMeasure DescriptionTime Frame
Adverse eventsIncidence of Adverse events following endoscopic procedures. Measured as percentage of individuals with an adverse event30-days and 60-days post-procedure
Diagnostic yieldDiagnostic yield after tissue sampling1-year follow up
Secondary Outcome MeasuresMeasure DescriptionTime Frame

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Name: Erik von Seth, MD, PhD

Phone Number: +46812380000

Email: erik.von.seth@ki.se

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person’s general health condition or prior treatments.

Ages Eligible for Study:
ALL

Sexes Eligible for Study:
18 Years

Accepts Healthy Volunteers:

    Inclusion Criteria:

  • Clinical indication for endoscopic intervention/procedure

  • Exclusion Criteria:

  • No informed consent
  • Age <18 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

  • Karolinska Institutet

  • PRINCIPAL_INVESTIGATOR: Erik von Seth, MD, PhD, Region Stockholm

Publications

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

No publications available